Volume thesis under pressure (organic +0%, price/mix -2%) but 8.1x PE and DCF P(above)=90.7% signals strong valuation support. 25% analyst upside. Upgrading from 4: impairments are non-cash and core brands resilient. Still no positive catalyst for re-rating.
Fair Value Distribution — percentile bands
95.4% of simulations place fair value above current price
WHAT IS PRICED IN
Revenue-Based Reverse DCF
-5.3%/yr
±3.3% · revenue growth to justify current price
FCF-Based Reverse DCF
1.8%/yr
±2.6% · FCF growth to justify current price
THE GAP
Market pricing margin compression or rising capex
KEY VALUE DRIVERS
Spearman correlation — what moves this valuation most
Eagle will generate this view by the next trading session (~7h).
Eagle will generate this view by the next trading session (~7h).
GIS trading volume decline accelerating into negative price mix territory. Organic net sales -1% YoY with organic price/mix at -2%, suggesting pricing power waning and consumers pulling back. Operatin...